• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自人内皮细胞条件培养基的活性和非活性纤溶酶原激活物抑制剂在免疫学和功能上相互关联。

The active and the inactive plasminogen activator inhibitor from human endothelial cell conditioned medium are immunologically and functionally related to each other.

作者信息

Sprengers E D, van Hinsbergh V W, Jansen B G

出版信息

Biochim Biophys Acta. 1986 Sep 4;883(2):233-41. doi: 10.1016/0304-4165(86)90313-2.

DOI:10.1016/0304-4165(86)90313-2
PMID:3091077
Abstract

In human endothelial cell conditioned medium a fast-acting inhibitor of tissue-type plasminogen activator and urokinase has been detected. Moreover, an inactive inhibitor of these plasminogen activators is present, that can be activated by denaturing agents such as sodium dodecyl sulphate (SDS). The mutual relationship between these inhibitors was studied. The fast-acting plasminogen activator inhibitor from human endothelial cell conditioned medium was purified in a complex with tissue-type plasminogen activator by immune adsorption, using an immobilized anti-tissue-type plasminogen activator antibody. With the complex as an antigen, specific antibodies were raised against this inhibitor in rabbits. The antiserum immunoreacted with both the inactive and the fast-acting plasminogen activator inhibitor. Endothelial cell conditioned medium (containing the inactive plasminogen activator inhibitor) was treated with SDS and the inhibitory activity that emerged was purified. The SDS-generated product formed complexes with tissue-type plasminogen activator with the same molecular mass as those formed with the fast-acting inhibitor. Moreover, the inhibitory activity generated by SDS treatment showed the same kinetic behaviour with tissue-type plasminogen activator as did the fast-acting inhibitor. These data show that the fast-acting and the inactive plasminogen activator inhibitor are immunologically and functionally related to each other, and probably represent different molecular forms of the same protein.

摘要

在人内皮细胞条件培养基中,已检测到一种组织型纤溶酶原激活剂和尿激酶的快速作用抑制剂。此外,还存在这些纤溶酶原激活剂的一种无活性抑制剂,其可被变性剂如十二烷基硫酸钠(SDS)激活。研究了这些抑制剂之间的相互关系。通过使用固定化抗组织型纤溶酶原激活剂抗体进行免疫吸附,从人内皮细胞条件培养基中纯化出与组织型纤溶酶原激活剂形成复合物的快速作用纤溶酶原激活剂抑制剂。以该复合物为抗原,在兔体内产生针对该抑制剂的特异性抗体。该抗血清与无活性和快速作用的纤溶酶原激活剂抑制剂均发生免疫反应。用SDS处理内皮细胞条件培养基(含有无活性纤溶酶原激活剂抑制剂),并纯化产生的抑制活性。SDS产生的产物与组织型纤溶酶原激活剂形成的复合物,其分子量与快速作用抑制剂形成的复合物相同。此外,SDS处理产生的抑制活性与组织型纤溶酶原激活剂的动力学行为,与快速作用抑制剂相同。这些数据表明,快速作用和无活性的纤溶酶原激活剂抑制剂在免疫学和功能上相互关联,可能代表同一蛋白质的不同分子形式。

相似文献

1
The active and the inactive plasminogen activator inhibitor from human endothelial cell conditioned medium are immunologically and functionally related to each other.来自人内皮细胞条件培养基的活性和非活性纤溶酶原激活物抑制剂在免疫学和功能上相互关联。
Biochim Biophys Acta. 1986 Sep 4;883(2):233-41. doi: 10.1016/0304-4165(86)90313-2.
2
Evidence for the presence of two different fibrinolytic inhibitors in human endothelial cell conditioned medium.人内皮细胞条件培养基中存在两种不同纤溶酶原激活物抑制剂的证据。
Biochim Biophys Acta. 1984 Sep 28;801(2):163-70. doi: 10.1016/0304-4165(84)90063-1.
3
Quantitation and properties of the active and latent plasminogen activator inhibitors in cultures of human endothelial cells.
Blood. 1986 May;67(5):1309-13.
4
Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.人软骨细胞培养物中一种特异性纤溶酶原激活物抑制剂的检测及部分特性分析
J Biochem. 1988 Dec;104(6):960-7. doi: 10.1093/oxfordjournals.jbchem.a122591.
5
Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.内毒素诱导牛肺动脉内皮细胞中纤溶酶原激活物抑制剂的产生
J Biol Chem. 1986 Jan 5;261(1):154-9.
6
Inhibition of plasminogen activators by conditioned medium of human hepatocytes and hepatoma cell line Hep G2.人肝细胞和肝癌细胞系Hep G2的条件培养基对纤溶酶原激活剂的抑制作用。
J Lab Clin Med. 1985 Jun;105(6):751-8.
7
Human endothelial cells produce a plasminogen activator inhibitor and a tissue-type plasminogen activator-inhibitor complex.人内皮细胞产生一种纤溶酶原激活物抑制剂和一种组织型纤溶酶原激活物-抑制剂复合物。
Biochim Biophys Acta. 1984 Nov 6;802(1):99-110. doi: 10.1016/0304-4165(84)90039-4.
8
Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.
Blood. 1985 Feb;65(2):444-51.
9
Purification of an active plasminogen activator inhibitor immunologically related to the endothelial type plasminogen activator inhibitor from the conditioned media of a human melanoma cell line.从人黑色素瘤细胞系的条件培养基中纯化一种与内皮型纤溶酶原激活物抑制剂具有免疫相关性的活性纤溶酶原激活物抑制剂。
J Biol Chem. 1986 Nov 5;261(31):14474-81.
10
An inhibitor of plasminogen activation from human placenta. Purification and characterization.人胎盘纤溶酶原激活抑制剂。纯化与特性鉴定。
J Biol Chem. 1987 Mar 15;262(8):3646-53.

引用本文的文献

1
Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for 'second-site' interactions.纤溶酶原激活物抑制剂对纤溶酶原激活物的抑制动力学。“第二位点”相互作用的证据。
Biochem J. 1988 Apr 15;251(2):327-32. doi: 10.1042/bj2510327.
2
The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator.人纤溶酶原激活物抑制剂1与组织纤溶酶原激活物之间的反应机制。
Biochem J. 1990 Jan 1;265(1):109-13. doi: 10.1042/bj2650109.